Vitamin O
This article was originally published in The Tan Sheet
Executive Summary
Two companies and their owner are permanently barred from making unsupported claims that Vitamin O prevents or effectively treats life-threatening conditions such as cancer, cardiovascular and pulmonary diseases, under an FTC consent order entered in Spokane, Wash. federal court April 28. Rose Creek Health Products, Staff of Life and Donald Smyth, president and sole shareholder of both firms, also are barred from claiming the supplement's effectiveness is established by medical or scientific research or studies unless they can substantiate those claims. The defendants will pay $375,000 in redress to settle an FTC lawsuit, filed in March 1999, alleging false and misleading advertising (1"The Tan Sheet" March 22, 1999, p. 6)
You may also be interested in...
Vitamin O Marketers Charged By FTC With "False And Misleading" Ad Claims
The Federal Trade Commission charges Rose Creek Health Products, The Staff of Life and Donald Smyth, owner of both entities, with violating the FTC Act for deceptively marketing its dietary supplement product Vitamin O in a complaint filed March 11 in Spokane, Wash. federal court.
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands